ArticleDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2004
[Anaplastic large cell lymphoma and keratoacanthoma].
Article in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 11 citations in OpenAlex.
- A clinical, histopathological and immunohistochemical approach to the bewildering diagnosis of keratoacanthoma.Journal of dentistry (Shiraz, Iran) · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In CD30 positive lymphoproliferative disorders, e.g. anaplastic large cell lymphoma (ALCL) and lymphomatoid papulosis (LyP), pseudoepitheliomatous hyperplasia may occur in up to 50 percent of the cases. Epithelial tumors are rarely associated with ALCL or LyP, but the presence of single CD30 positive cells among the infiltrate accompanying epithelial tumors such as basal cell carcinomas and keratoacanthomas is well known. A 66-year-old man developed within a plaque of ALCL a rapidly growing epithelial tumor which we classified according to the clinical and histological features as keratoacanthoma. This case underlines the intimate interaction between CD30 positive lymphocytes and epithelial cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.